醫療季營收分析

最後更新 2026-03-25 08:40:09 (UTC+8)

醫療季營收趨勢分析

判斷醫療類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療類股調整後季營收與 XLV ETF走勢圖

FindBillion.com

季節調整後季營收成長率


季營收季增率	0.8%
季營收年增率	10.4%

醫療季營收與股價相關性分析

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療類股整體季節調整後季營收-股價散佈圖

醫療類股整體季節調整後季營收與股價高度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季營收與股價間的
決定係數

高度相關 0.87

FindBillion.com

醫療相關個股

醫療相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。

代碼	公司名稱	季營收季增率	季營收年增率
CYTK	Cytokinetics, Incorporated	888%	4.9%
GMAB	Genmab A/S	339.5%	4.4%
ARGX	argenx SE	242.8%	319.8%
BBIO	BridgeBio Pharma, Inc.	198%	2521.2%
ONC	BeOne Medicines Ltd.	75.9%	32.8%
INSM	Insmed Incorporated	67.7%	152.6%
ABVX	Abivax S.A.	30.8%	-10.3%
AXSM	Axsome Therapeutics, Inc.	28.5%	65%
MDGL	Madrigal Pharmaceuticals, Inc.	25.9%	210.8%
TEM	Tempus AI, Inc.	24.5%	83%
NTRA	Natera, Inc.	14.1%	39.8%
BMRN	BioMarin Pharmaceutical Inc.	13.2%	17%
DVA	DaVita Inc.	9.8%	9.9%
ENSG	The Ensign Group, Inc.	9.6%	20.2%
MEDP	Medpace Holdings, Inc.	8.2%	32%
BTSG	BrightSpring Health Services, Inc. Common Stock	8.1%	16.3%
PODD	Insulet Corporation	6.7%	31.2%
PEN	Penumbra, Inc.	6%	22.1%
CI	Cigna Corporation	5.7%	10.4%
UTHR	United Therapeutics Corporation	5.3%	7.4%
NBIX	Neurocrine Biosciences, Inc.	5.2%	28.3%
HLN	Haleon plc	5.1%	98.4%
ATR	AptarGroup, Inc.	5%	13.5%
ISRG	Intuitive Surgical, Inc.	5%	18.8%
SYK	Stryker Corporation	5%	11.4%
DHR	Danaher Corporation	4.6%	4.6%
SNN	Smith & Nephew plc	4.5%	13.3%
ALGN	Align Technology, Inc.	4%	5.3%
HUM	Humana Inc.	4%	11.3%
VEEV	Veeva Systems Inc.	3.9%	16%
TAK	Takeda Pharmaceutical Company Limited	3.8%	6%
ILMN	Illumina, Inc.	3.7%	5%
JAZZ	Jazz Pharmaceuticals plc	3.6%	10.1%
ABBV	AbbVie Inc.	3.2%	10%
SNY	Sanofi	3.2%	59.9%
EXEL	Exelixis, Inc.	3%	5.6%
CNC	Centene Corporation	2.9%	21.9%
ALC	Alcon Inc.	2.8%	8.6%
TECH	Bio-Techne Corporation	2.3%	-0.4%
MASI	Masimo Corporation	2%	-31.3%
MCK	McKesson Corporation	2%	11.4%
INCY	Incyte Corporation	1.7%	27.8%
IDXX	IDEXX Laboratories, Inc.	1.6%	14.3%
RMD	ResMed Inc.	1.6%	11%
MTD	Mettler-Toledo International Inc.	1.6%	8.1%
STE	STERIS plc	1.4%	9.2%
PFE	Pfizer Inc.	1.3%	-1.2%
BSX	Boston Scientific Corporation	1.2%	15.9%
COR	Cencora, Inc.	1.1%	5.5%
FMS	Fresenius Medical Care AG & Co. KGaA	1.1%	-0.3%
THC	Tenet Healthcare Corporation	1%	9%
TMO	Thermo Fisher Scientific Inc.	0.9%	7.2%
UNH	UnitedHealth Group Incorporated	0.6%	12.3%
DGX	Quest Diagnostics Incorporated	0.5%	7.1%
VRTX	Vertex Pharmaceuticals Incorporated	0.5%	10.8%
MDT	Medtronic plc	0.3%	8.8%
EXAS	Exact Sciences Corporation	0.3%	23.1%
RPRX	Royalty Pharma plc	0.2%	4.8%
CVS	CVS Health Corporation	0.2%	8.2%
ZBH	Zimmer Biomet Holdings, Inc.	0.2%	10.9%
GILD	Gilead Sciences, Inc.	0.2%	4.7%
EHC	Encompass Health Corporation	0.1%	9.9%
WST	West Pharmaceutical Services, Inc.	-	7.5%
MOH	Molina Healthcare, Inc.	-0.1%	8.3%
LLY	Eli Lilly and Company	-0.5%	42.6%
IBRX	ImmunityBio, Inc.	-0.6%	407%
ELV	Elevance Health Inc.	-0.7%	9.5%
AMGN	Amgen Inc.	-0.7%	8.9%
NVO	Novo Nordisk A/S	-0.7%	-8.5%
JNJ	Johnson & Johnson	-0.8%	9.1%
COO	The Cooper Companies, Inc.	-0.8%	6.2%
IQV	IQVIA Holdings Inc.	-1.1%	10.3%
EW	Edwards Lifesciences Corporation	-1.2%	13.3%
ZTS	Zoetis Inc.	-1.3%	3%
A	Agilent Technologies, Inc.	-1.3%	7%
CAH	Cardinal Health, Inc.	-1.4%	18.4%
HCA	HCA Healthcare, Inc.	-1.5%	6.7%
HSIC	Henry Schein, Inc.	-1.6%	7.7%
GSK	GSK plc	-1.6%	6.2%
TEVA	Teva Pharmaceutical Industries Limited	-1.6%	11.4%
RVTY	Revvity, Inc.	-1.6%	5.9%
BMY	Bristol-Myers Squibb Company	-1.7%	1.3%
ABT	Abbott Laboratories	-1.7%	4.4%
ELAN	Elanco Animal Health Incorporated	-1.8%	12.2%
CRL	Charles River Laboratories International, Inc.	-2.3%	-0.8%
AZN	AstraZeneca PLC	-2.3%	4.1%
GH	Guardant Health, Inc.	-2.4%	39.4%
UHS	Universal Health Services, Inc.	-2.4%	9.1%
GMED	Globus Medical, Inc.	-2.4%	25.7%
MRK	Merck & Co., Inc.	-2.6%	5%
DXCM	DexCom, Inc.	-2.9%	13.1%
SOLV	Solventum Corporation	-3.1%	-3.7%
REGN	Regeneron Pharmaceuticals, Inc.	-3.4%	2.5%
HALO	Halozyme Therapeutics, Inc.	-3.7%	51.6%
BAX	Baxter International Inc.	-3.7%	8%
PHG	Koninklijke Philips N.V.	-3.8%	1.1%
WAT	Waters Corporation	-3.9%	6.8%
VTRS	Viatris Inc.	-3.9%	5%
QGEN	Qiagen N.V.	-4.6%	3.7%
ICLR	ICON Public Limited Company	-4.9%	0.6%
HOLX	Hologic, Inc.	-5%	2.5%
LH	Labcorp Holdings Inc.	-5.3%	5.6%
BDX	Becton, Dickinson and Company	-5.3%	1.6%
BIIB	Biogen Inc.	-5.9%	-7.1%
NVS	Novartis AG	-11.8%	-1.6%
ARWR	Arrowhead Pharmaceuticals, Inc.	-13%	10461.3%
GEHC	GE HealthCare Technologies Inc.	-15.2%	-12.1%
KRYS	Krystal Biotech, Inc.	-23.7%	17.5%
ALNY	Alnylam Pharmaceuticals, Inc.	-24.7%	84.9%
IONS	Ionis Pharmaceuticals, Inc.	-24.7%	-10.4%
ASND	Ascendis Pharma A/S	-25.7%	41%
MRNA	Moderna, Inc.	-43.4%	-29.1%
RDY	Dr. Reddy's Laboratories Limited	-52.2%	4.4%
BNTX	BioNTech SE	-57.7%	-24.5%
ROIV	Roivant Sciences Ltd.	-61.8%	-77.8%
RGC	Regencell Bioscience Holdings Limited	-	-
PCVX	Vaxcyte, Inc.	-	-
SMMT	Summit Therapeutics Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-
MDLN	Medline Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股

醫療季營收趨勢分析

判斷 醫療 類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療季營收與股價相關性分析

判斷 醫療 類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股

醫療 相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。

判斷醫療類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。